13F HOLDINGS REPORT
MWG Caph Ltd
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001193125-26-053978
Total Value
$72.4M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 1,266,934 | $35.1M | 48.53% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 1,008,116 | $31.0M | 42.88% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $6.2M | 8.59% |